Prognostic and predictive markers in pancreatic adenocarcinoma
about
Web-based tools for microRNAs involved in human cancer.Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry dataAssociation between periodontitis and prognosis of pancreatobiliary tract cancer: A pilot study.Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patientsAberrant expression of nuclear HDAC3 and cytoplasmic CDH1 predict a poor prognosis for patients with pancreatic cancerNovel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.Current and future biomarkers for pancreatic adenocarcinoma.miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy.Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancerPolyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease.MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer.ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
P2860
Q30489440-1A101E7A-4DA1-4589-A43F-D258977D8FADQ31172638-5C6EFEB7-F639-451C-A88C-1B3639141627Q33685178-6C3CC316-3117-4391-985C-503249148B62Q33774197-56D0FA56-5336-4B48-BF71-C0EE389C3D57Q37086067-67978EC4-B7EF-4803-A615-EEDBB9808D44Q37641644-1499EE1E-1BD4-4392-BBFB-D4BE199A9E10Q37655299-772B24F2-37A0-4FA1-BAAA-CDE4D183F7CAQ38670577-6D6A6349-B4C1-445B-9F6B-B6B7157E7F8BQ38709890-5AD71AB6-AF72-4FA3-9748-7BA873125A68Q39410445-9B600028-FA80-45D7-A4A1-8186F097AF7CQ40039447-CB8EC082-D14E-432A-AE2C-F05E60A16460Q41672310-D8A61219-1C87-4102-981A-26639116B407Q41838741-40166EC3-736E-42CD-B7A5-2EC4C94C3E1FQ42154484-46567D08-D59D-43B6-A63A-35B3588CE565Q43434762-BCFCA436-56AE-4622-988C-DCACDC555BAEQ45177278-47F9F13F-6251-44A0-BF63-872C290C0FF9Q49335779-D9BAA99C-F498-4B42-A9FF-22E28644616EQ49388105-1F9F0169-6D56-4268-8FCC-6D743C703992Q50080994-4C1FD46C-60DC-4EA3-87E4-0D065809713EQ54980764-6D4BA3AC-8496-4741-9C8F-E6C852B69B6B
P2860
Prognostic and predictive markers in pancreatic adenocarcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Prognostic and predictive markers in pancreatic adenocarcinoma
@ast
Prognostic and predictive markers in pancreatic adenocarcinoma
@en
Prognostic and predictive markers in pancreatic adenocarcinoma
@nl
type
label
Prognostic and predictive markers in pancreatic adenocarcinoma
@ast
Prognostic and predictive markers in pancreatic adenocarcinoma
@en
Prognostic and predictive markers in pancreatic adenocarcinoma
@nl
prefLabel
Prognostic and predictive markers in pancreatic adenocarcinoma
@ast
Prognostic and predictive markers in pancreatic adenocarcinoma
@en
Prognostic and predictive markers in pancreatic adenocarcinoma
@nl
P1476
Prognostic and predictive markers in pancreatic adenocarcinoma
@en
P2093
P304
P356
10.1016/J.DLD.2015.11.001
P407
P50
P577
2016-03-01T00:00:00Z